Catalyst Wire Dossier Catalyst Wire Dossier

CRENEOUS ENTERPRISE 2 Intracranial Stent

· Medos International SARL
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRENEOUS ENTERPRISE 2 Intracranial Stent, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis [NA]

See pricing